Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.98
Delayed Data
As of 3:58pm ET
 +0.0048 / +0.24%
Today’s Change
1.72
Today|||52-Week Range
3.09
-5.03%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.98
Today’s open2.00
Day’s range1.95 - 2.01
Volume19,018
Average volume (3 months)41,850
Market cap$34.0M
Dividend yield--
Data as of 3:58pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
PRPHProPhase Labs Inc+0.10+5.10%
FCSCFibrocell Science In...-0.03-4.00%
CTRVContraVir Pharmaceut...-0.03-2.75%
TKAITokai Pharmaceutical...-0.05-3.23%
Data as of 3:59pm ET, 09/28/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Search for Jobs